TG
TEVA icon

TCW Group’s Teva Pharmaceuticals TEVA Stock Holding History

TCW Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-170,350
Closed -$5.13M – 659
2026
Q1 		$5.13M Buy
170,350
+21,930
+15% +$706K 0.04% 186
2025
Q4 		$4.63M Sell
148,420
-37,048
-20% -$913K 0.03% 178
2025
Q3 		$3.75M Buy
185,468
+58,509
+46% +$1.03M 0.03% 162
2025
Q2 		$2.13M Sell
126,959
-8,243
-6% -$133K 0.02% 255
2025
Q1 		$2.08M Buy
135,202
+26,105
+24% +$466K 0.02% 249
2024
Q4 		$2.4M Buy
109,097
+37,707
+53% +$686K 0.02% 243
2024
Q3 		$1.29M Buy
+71,390
New +$1.25M 0.01% 283
2016
Q4 		– Sell
-71,914
Closed -$3.31M – 703
2016
Q3 		$3.31M Sell
71,914
-63,137
-47% -$3.29M 0.03% 233
2016
Q2 		$6.78M Buy
135,051
+4,715
+4% +$251K 0.05% 163
2016
Q1 		$6.97M Buy
130,336
+29,339
+29% +$1.72M 0.05% 160
2015
Q4 		$6.63M Buy
+100,997
New +$6.24M 0.05% 166
2015
Q2 		– Sell
-35,068
Closed -$2.18M – 717
2015
Q1 		$2.18M Sell
35,068
-2,711
-7% -$158K 0.01% 609
2014
Q4 		$2.17M Buy
37,779
+2,729
+8% +$152K 0.01% 602
2014
Q3 		$1.88M Buy
35,050
+12,593
+56% +$667K 0.01% 672
2014
Q2 		$1.18M Buy
+22,457
New +$1.15M ﹤0.01% 694

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

TCW Group's TEVA Position: Q2 2026 in Review

TCW Group sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 170,350 shares — an estimated $5.13M sold.

TCW Group first reported a position in TEVA in Q2 2014 and held it in 15 quarters. The position peaked at $6.97M in Q1 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TCW Group reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TCW Group sold 170,350 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.13M.
  • TCW Group first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 15 quarters.
  • TCW Group's Teva Pharmaceuticals position peaked at $6.97M in Q1 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.